Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 35, Issue 5, Pages 327–330
http://dx.doi.org/10.1155/2013/327604
Research Article

Brain Hypothermic Therapy Dramatically Decreases Elevated Blood Concentrations of High Mobility Group Box 1 in Neonates with Hypoxic-Ischemic Encephalopathy

1National Hospital Organization, Nishisaitama-Chuo National Hospital, Japan
2Central Institute, Shino-Test Corporation, 2-29-14 Oonodai Minami-Ku, Sagamihara-Shi, Kanagawa-Ken 252-0331, Japan

Received 12 June 2013; Accepted 23 August 2013

Academic Editor: Timothy M. Block

Copyright © 2013 Toshihiko Nakamura et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. H. Goodwin, C. Sanders, and E. W. Johns, “A new group of chromatin associated proteins with a high content of acidic and basic amino acids,” European Journal of Biochemistry, vol. 38, no. 1, pp. 14–19, 1973. View at Google Scholar · View at Scopus
  2. H. Wang, O. Bloom, M. Zhang et al., “HMG-1 as a late mediator of endotoxin lethality in mice,” Science, vol. 285, no. 5425, pp. 248–251, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Scaffidi, T. Misteli, and M. E. Bianchi, “Release of chromatin protein HMGB1 by necrotic cells triggers inflammation,” Nature, vol. 418, no. 6894, pp. 191–191, 2002. View at Google Scholar · View at Scopus
  4. H. Wang, H. Yang, C. J. Czura, A. E. Sama, and K. J. Tracey, “HMBG1 as a late mediator of lethal systemic inflammation,” American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 10, pp. 1768–1773, 2001. View at Google Scholar · View at Scopus
  5. H. Wang, H. Yang, and K. J. Tracey, “Extracellular role of HMGB1 in inflammation and sepsis,” Journal of Internal Medicine, vol. 255, no. 3, pp. 320–331, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Wang, H. Yang, C. J. Czura, A. E. Sama, and K. J. Tracey, “HMGB-1 as a late mediator of lethal systemic inflammation,” American Journal of Respiratory and Critical Care Medicinel, vol. 164, no. 10, part 1, pp. 1768–1773, 2001. View at Publisher · View at Google Scholar
  7. S. Gaïni, S. S. Pedersen, O. G. Koldkjaer, C. Pedersen, and H. J. Møller, “High mobility group box-1 protein in patients with suspected community-acquired infections and sepsis: a prospective study,” Critical Care, vol. 11, no. 2, p. R32, 2007. View at Google Scholar · View at Scopus
  8. J. Sundén-Cullberg, A. Norrby-Teglund, A. Rouhiainen et al., “Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock,” Critical Care Medicine, vol. 33, no. 3, pp. 564–573, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Yamada, K. Yakabe, J. Ishii, H. Imaizumi, and I. Maruyama, “New high mobility group box 1 assay system,” Clinica Chimica Acta, vol. 372, no. 1-2, pp. 173–178, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. R. S. Goldstein, M. Gallowitsch-Puerta, L. Yang et al., “Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia,” Shock, vol. 25, no. 6, pp. 571–574, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Hatada, H. Wada, T. Nobori et al., “Plasma concentrations and importance of high mobility group box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation,” Thrombosis and Haemostasis, vol. 94, no. 5, pp. 975–979, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. J. J. Volpe, “Hypoxic-ischemic encephalopathy,” in Neurology of the Newborn, pp. 245–480, Saunders, Philadelphia, Pa, USA, 2008. View at Google Scholar
  13. T. Nakamura, S. Yamada, and T. Yoshioka, “Measurement of plasma concentration of high mobility group box1 (HMGB1) in early neonates and evaluation of its usefulness,” Clinica Chimica Acta, vol. 413, no. 1-2, pp. 237–239, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Okazaki, M. Kondo, M. Kato et al., “Elevation of high-mobility group box 1 concentration in asphyxiated neonates,” Neonatology, vol. 94, no. 2, pp. 105–109, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Faraco, S. Fossati, M. E. Bianchi et al., “High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo,” Journal of Neurochemistry, vol. 103, no. 2, pp. 590–603, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Qiu, M. Nishimura, Y. Wang et al., “Early release of HMGB-1 from neurons after the onset of brain ischemia,” Journal of Cerebral Blood Flow and Metabolism, vol. 28, no. 5, pp. 927–938, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Song, Y. Feng, S. Hoeger et al., “High mobility group box 1 and adenosine are both released by endothelial cells during hypothermic preservation,” Clinical and Experimental Immunology, vol. 152, no. 2, pp. 311–319, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. A.-G. Ceulemans, T. Zgavc, R. Kooijman, S. Hachimi-Idrissi, S. Sarre, and Y. Michotte, “The dual role of the neuroinflammatory response after ischemic stroke: modulatory effects of hypothermia,” Journal of Neuroinflammation, vol. 7, article 74, 2010. View at Publisher · View at Google Scholar · View at Scopus